Yungjin Pharm Co Ltd (003520) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.078x

Based on the latest financial reports, Yungjin Pharm Co Ltd (003520) has a cash flow conversion efficiency ratio of 0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.00 Billion ≈ $4.74 Million USD) by net assets (₩90.02 Billion ≈ $61.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yungjin Pharm Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Yungjin Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Yungjin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yungjin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yungjin Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Gevelot PA:ALGEV	0.039x
St.Shine Optical Co Ltd TWO:1565	0.059x
Torrid Holdings Inc NYSE:CURV	0.028x
TGE Value Creative Solutions Corp NYSE:BEBE	0.019x
Ekovest Bhd KLSE:8877	0.028x
Borosil Scientific NSE:BOROSCI	N/A
DAEA TI Co. Ltd KQ:045390	-0.059x
IG Petrochemicals Limited NSE:IGPL	-0.029x

Annual Cash Flow Conversion Efficiency for Yungjin Pharm Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Yungjin Pharm Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Yungjin Pharm Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩89.80 Billion ≈ $60.86 Million	₩21.74 Billion ≈ $14.73 Million	0.242x	+312.24%
2023-12-31	₩89.63 Billion ≈ $60.74 Million	₩-10.22 Billion ≈ $-6.93 Million	-0.114x	+11.70%
2022-12-31	₩89.87 Billion ≈ $60.90 Million	₩-11.61 Billion ≈ $-7.87 Million	-0.129x	-261.92%
2021-12-31	₩104.89 Billion ≈ $71.08 Million	₩8.37 Billion ≈ $5.67 Million	0.080x	-37.03%
2020-12-31	₩114.43 Billion ≈ $77.55 Million	₩14.50 Billion ≈ $9.82 Million	0.127x	+57.98%
2019-12-31	₩115.75 Billion ≈ $78.44 Million	₩9.28 Billion ≈ $6.29 Million	0.080x	+602.43%
2018-12-31	₩111.61 Billion ≈ $75.63 Million	₩1.27 Billion ≈ $863.49K	0.011x	-56.66%
2017-12-31	₩119.65 Billion ≈ $81.08 Million	₩3.15 Billion ≈ $2.14 Million	0.026x	-10.13%
2016-12-31	₩106.17 Billion ≈ $71.95 Million	₩3.11 Billion ≈ $2.11 Million	0.029x	-66.56%
2015-12-31	₩100.42 Billion ≈ $68.06 Million	₩8.80 Billion ≈ $5.96 Million	0.088x	+42.11%
2014-12-31	₩100.79 Billion ≈ $68.30 Million	₩6.22 Billion ≈ $4.21 Million	0.062x	+6.13%
2013-12-31	₩102.45 Billion ≈ $69.43 Million	₩5.95 Billion ≈ $4.03 Million	0.058x	--

About Yungjin Pharm Co Ltd

KO:003520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$148.98 Million

₩219.84 Billion KRW

Market Cap Rank

#17750 Global

#743 in Korea

Share Price

₩1202.00

Change (1 day)

-4.22%

52-Week Range

₩1202.00 - ₩2360.00

All Time High

₩17500.00